Avadel Pharmaceuticals Plc Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2024
Revenue & cost
Revenue 53.93M33.60M32.60M7.53M4.18M14.97M173.01M150.25M173.25M103.27M59.22M22.33M-10.83M
Cost of Revenue 10.12M6.91M6.28M0.40M0.56M3.38M11.41M13.25M16.30M17.52M12.12M5.74M
Gross Profit 43.81M26.69M26.32M7.13M3.62M11.59M161.60M137.00M156.94M85.75M47.09M16.59M
Operating items
Amortization - Intangibles 11.75M12.56M13.89M3.66M6.62M0.82M0.41M
Research & Development -30.42M28.69M25.09M14.56M15.97M17.30M25.61M34.61M33.42M39.33M32.92M20.44M17.10M
Selling, General & Administrative -13.34M11.33M10.81M14.15M13.22M15.70M21.71M44.18M58.86M100.36M30.18M32.41M68.50M
Restructuring Costs 28.14M57.49M30.96M49.28M-31.04M-22.73M0.84M3.33M
Other Operating Expenses -10.12M6.91M6.28M-11.26M0.56M18.14M23.97M27.14M22.50M91.24M19.38M45.76M-0.05M
Operating Expenses -53.87M46.93M42.18M17.45M57.88M108.63M102.25M155.21M83.74M208.19M83.33M16.52M85.55M
Operating Income -11.75M-9.84M-9.58M-9.91M-53.70M-93.66M70.76M-4.96M89.50M-104.93M-24.11M5.82M-85.55M
EBIT -11.75M-9.84M-9.58M-9.91M-53.70M-93.66M70.76M-4.96M89.50M-104.93M-24.11M5.82M-85.55M
Non-operating items
Interest & Investment Income 0.53M0.46M0.67M0.63M0.25M0.93M1.24M1.64M2.85M0.45M1.07M-0.83M
Other Non Operating Income -0.08M0.53M0.27M-0.18M0.57M11.87M10.59M-6.55M2.07M1.90M-0.38M-0.43M
Non Operating Income 0.57M-0.04M-4.88M-6.55M2.07M1.90M-0.38M-0.43M
Net income details
EBT 1.80M-8.77M-8.58M-9.47M-57.75M-90.13M77.70M-9.72M92.66M-113.20M-81.39M-18.43M-85.55M
Tax Provisions 0.21M0.19M-4.73M-11.24M-0.64M35.91M31.56M24.39M-17.89M-5.36M-12.11M
Profit After Tax -11.44M-8.97M-8.77M-4.74M-46.51M-89.49M41.80M-41.28M68.27M-95.30M-33.23M7.03M-85.55M
Investment Income -0.82M0.20M0.56M
Income from Continuing Operations 1.80M-8.97M-8.77M-4.74M-46.51M-89.49M41.80M-41.28M68.27M-95.30M-76.03M-6.32M-85.55M
Consolidated Net Income 1.80M-8.97M-8.77M1.51M3.58M4.02M41.80M-41.28M68.27M-95.30M-76.03M-6.32M-85.55M
Income towards Parent Company 1.80M-8.97M-8.77M1.51M3.58M4.02M41.80M-41.28M68.27M-95.30M-76.03M-6.32M-85.55M
Net Income towards Common Stockholders 1.80M-8.97M-8.77M1.51M3.58M4.02M41.80M-41.28M68.27M-95.30M-76.03M-6.32M-85.55M
Additional items
EPS (Basic) -0.47-0.37-0.36-0.19-1.83-2.471.03-1.001.69-2.55-0.890.13-1.46
EPS (Weighted Average and Diluted) -0.47-0.37-0.36-0.19-1.83-2.470.96-1.001.63-2.55-0.890.13
Shares Outstanding (Weighted Average) 24.21M24.34M24.65M24.96M24.96M25.61M40.19M41.24M39.76M37.01M37.45M58.27M58.62M
Shares Outstanding (Diluted Average) 35.77M32.39M34.34M32.60M0.03M36.21M43.62M41.25M41.77M37.33M37.40M54.94M
EBITDA -11.75M-9.84M-9.58M-9.91M-53.70M-93.66M70.76M-4.96M89.50M-104.93M-24.11M5.82M-85.55M
Interest Expenses 0.10M0.02M0.07M0.12M2.60M5.75M0.96M1.05M10.62M12.48M12.99M10.83M
Tax Rate 49.94%19.47%0.71%46.21%26.32%15.81%6.58%65.71%